BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12630378)

  • 1. The ever-changing HIV treatment landscape.
    Berger DS
    Posit Aware; 2003; 14(1):69-70, 76. PubMed ID: 12630378
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV integrase inhibitors show potent activity in clinical trials.
    Winslow DL
    AIDS Alert; 2007 Jan; 22(1):10-1. PubMed ID: 17722343
    [No Abstract]   [Full Text] [Related]  

  • 3. Update on experimental antiretrovirals.
    Proj Inf Perspect; 2007 Oct; (44):8-19. PubMed ID: 18046833
    [No Abstract]   [Full Text] [Related]  

  • 4. New antiretroviral agents and the complexity of treatment practices.
    Smith D
    J HIV Ther; 2008 Jun; 13(2):25-6. PubMed ID: 18953270
    [No Abstract]   [Full Text] [Related]  

  • 5. How HIV drugs work 101.
    Pietrandoni G
    Posit Aware; 2001; 12(5):26-7. PubMed ID: 11688481
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV treatment and the nonclinician: getting your bearings.
    HRSA Careaction; 2007 Jan; ():1-12. PubMed ID: 17380596
    [No Abstract]   [Full Text] [Related]  

  • 7. Rescue regimens: the value of protease-inhibitor boosting.
    Segal-Maurer S; Schütz M
    Body Posit; 2001 Sep; 14(9):11-3. PubMed ID: 11693112
    [No Abstract]   [Full Text] [Related]  

  • 8. 13th annual HIV drug guide.
    Djuricich P; Vázquez E
    Posit Aware; 2009; 20(2):28-55. PubMed ID: 19280745
    [No Abstract]   [Full Text] [Related]  

  • 9. 12th annual HIV drug guide.
    Diaz-Linares M; Vázquez E; Gallant J; Delaney M
    Posit Aware; 2008; 19(1):19-48. PubMed ID: 18546577
    [No Abstract]   [Full Text] [Related]  

  • 10. Consider these initial combination regimens.
    AIDS Alert; 2010 Apr; 25(4):40. PubMed ID: 20556895
    [No Abstract]   [Full Text] [Related]  

  • 11. Protease inhibitors in children: combination therapy reduced death by two thirds.
    James JS
    AIDS Treat News; 2001 Nov; (374):4-5. PubMed ID: 11775935
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of antiretroviral drug resistance.
    Wainberg MA; Zaharatos GJ; Brenner BG
    N Engl J Med; 2011 Aug; 365(7):637-46. PubMed ID: 21848464
    [No Abstract]   [Full Text] [Related]  

  • 13. Protease inhibitors: opium of the masses?
    Martinez LJ
    Res Initiat Treat Action; 2000 Sep; 6(3):7-11. PubMed ID: 11708167
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV's potent cocktail.
    Lusky K
    Contemp Longterm Care; 1999 Dec; 22(12):59. PubMed ID: 10977335
    [No Abstract]   [Full Text] [Related]  

  • 15. Teaching adherence to substance users.
    TreatmentUpdate; 2002; 14(4):4-5. PubMed ID: 12064315
    [No Abstract]   [Full Text] [Related]  

  • 16. ABC in the news.
    Carter M
    IAPAC Mon; 2006 Jun; 12(6):178-9. PubMed ID: 17233104
    [No Abstract]   [Full Text] [Related]  

  • 17. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.
    Wilkins E
    J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-HIV agents. Saquinavir--switching from Fortovase to Invirase.
    TreatmentUpdate; 2004; 16(3):8-9. PubMed ID: 17219608
    [No Abstract]   [Full Text] [Related]  

  • 19. New versions of antiretroviral guidelines contain some important changes.
    Murphy MJ
    Fac Notes (New Orleans La); 1999; 11(4):1-3. PubMed ID: 11810843
    [No Abstract]   [Full Text] [Related]  

  • 20. Controversies in current treatment guidelines.
    Gazzard BG
    J HIV Ther; 2008 Mar; 13(1):1-3. PubMed ID: 18953266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.